Michael H. Rivner

5.2k total citations
38 papers, 1.5k citations indexed

About

Michael H. Rivner is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Michael H. Rivner has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Michael H. Rivner's work include Myasthenia Gravis and Thymoma (10 papers), Peripheral Neuropathies and Disorders (10 papers) and Amyotrophic Lateral Sclerosis Research (7 papers). Michael H. Rivner is often cited by papers focused on Myasthenia Gravis and Thymoma (10 papers), Peripheral Neuropathies and Disorders (10 papers) and Amyotrophic Lateral Sclerosis Research (7 papers). Michael H. Rivner collaborates with scholars based in United States, Japan and Germany. Michael H. Rivner's co-authors include Thomas R. Swift, Khalid Mahmood Malik, Kapil D. Sethi, Lin Mei, Robert K. Yu, Seigo Usuki, Rup Tandan, Gareth Parry, P. D. Donofrio and Jerry R. Mendell and has published in prestigious journals such as Neurology, Neuroscience and PLoS Medicine.

In The Last Decade

Michael H. Rivner

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael H. Rivner United States 19 890 403 352 278 205 38 1.5k
C Swanson United States 21 849 1.0× 259 0.6× 664 1.9× 619 2.2× 382 1.9× 43 2.1k
Ming‐Hong Chang Taiwan 20 339 0.4× 176 0.4× 403 1.1× 325 1.2× 311 1.5× 81 1.4k
Vivian E. Drory Israel 26 1.3k 1.5× 145 0.4× 286 0.8× 157 0.6× 303 1.5× 100 2.2k
David N. Herrmann United States 16 736 0.8× 212 0.5× 414 1.2× 137 0.5× 567 2.8× 33 1.5k
Alfred C. Lais United States 14 454 0.5× 185 0.5× 445 1.3× 158 0.6× 473 2.3× 20 1.1k
David N. Herrmann United States 22 883 1.0× 97 0.2× 799 2.3× 161 0.6× 645 3.1× 69 1.8k
Hideto Miwa Japan 24 1.0k 1.2× 68 0.2× 545 1.5× 101 0.4× 152 0.7× 109 1.7k
Páll Karlsson Denmark 23 670 0.8× 109 0.3× 279 0.8× 131 0.5× 849 4.1× 61 1.5k
Grazia Devigili Italy 24 1.7k 1.9× 110 0.3× 622 1.8× 146 0.5× 1.2k 6.0× 63 2.7k
Akira Inaba Japan 13 510 0.6× 93 0.2× 282 0.8× 62 0.2× 98 0.5× 43 1.0k

Countries citing papers authored by Michael H. Rivner

Since Specialization
Citations

This map shows the geographic impact of Michael H. Rivner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Rivner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Rivner more than expected).

Fields of papers citing papers by Michael H. Rivner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Rivner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Rivner. The network helps show where Michael H. Rivner may publish in the future.

Co-authorship network of co-authors of Michael H. Rivner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Rivner. A scholar is included among the top collaborators of Michael H. Rivner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Rivner. Michael H. Rivner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrin, Steven, Shafeeq Ladha, Nicholas J. Maragakis, et al.. (2024). Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial. PLoS Medicine. 21(10). e1004469–e1004469. 2 indexed citations
2.
Yan, Min, Ziyang Liu, Erkang Fei, et al.. (2018). Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice. Neuroscience. 373. 113–121. 26 indexed citations
3.
Rivner, Michael H., Mamatha Pasnoor, Mazen M. Dimachkie, Richard J. Barohn, & Lin Mei. (2018). Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies. Neurologic Clinics. 36(2). 293–310. 28 indexed citations
4.
Cordts, Isabell, John Tzartos, Lin Mei, et al.. (2017). Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis. Journal of Neurology. 264(6). 1193–1203. 33 indexed citations
5.
Berry, James D., Sabrina Paganoni, Nazem Atassi, et al.. (2015). A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067). Neurology. 84(14_supplement). 1 indexed citations
6.
Usuki, Seigo, et al.. (2014). A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples. Journal of Immunological Methods. 408. 52–63. 5 indexed citations
7.
Braddom, Randall L., et al.. (2009). Frequency of radiculopathies in motor vehicle accidents. Muscle & Nerve. 39(4). 545–547. 6 indexed citations
8.
Usuki, Seigo, Yukihiko Ito, Keiko Morikawa, et al.. (2007). Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats. Nutrition & Metabolism. 4(1). 25–25. 36 indexed citations
9.
Usuki, Seigo, Stuart A. Thompson, Michael H. Rivner, et al.. (2005). Molecular mimicry: Sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside. Journal of Neuroscience Research. 83(2). 274–284. 20 indexed citations
10.
Usuki, Seigo, Juan A. Sánchez, Toshio Ariga, et al.. (2005). AIDP and CIDP having specific antibodies to the carbohydrate epitope (–NeuAcα2–8NeuAcα2–3Galβ1–4Glc–) of gangliosides. Journal of the Neurological Sciences. 232(1-2). 37–44. 17 indexed citations
11.
Mendell, Jerry R., Richard J. Barohn, Miriam Freimer, et al.. (2001). Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 56(4). 445–449. 243 indexed citations
12.
Rivner, Michael H.. (2001). The neurophysiology of myofascial pain syndrome. Current Pain and Headache Reports. 5(5). 432–440. 52 indexed citations
13.
Rivner, Michael H., Thomas R. Swift, & Khalid Mahmood Malik. (2001). Influence of age and height on nerve conduction. Muscle & Nerve. 24(9). 1134–1141. 194 indexed citations
14.
Tarsy, Daniel, David Kaufman, Kapil D. Sethi, et al.. (1997). An Open-Label Study of Botulinum Toxin A for Treatment of Tardive Dystonia. Clinical Neuropharmacology. 20(1). 90–93. 45 indexed citations
15.
Rivner, Michael H.. (1994). Statistical errors and their effect on electrodiagnostic medicine. Muscle & Nerve. 17(7). 811–814. 26 indexed citations
16.
Rivner, Michael H. & Thomas R. Swift. (1990). Thymoma: Diagnosis and Management. Seminars in Neurology. 10(1). 83–88. 9 indexed citations
17.
Rivner, Michael H., et al.. (1989). Kearns‐Sayre syndrome and complex II deficiency. Neurology. 39(5). 693–693. 57 indexed citations
18.
Gulati, Adarsh K., Michael H. Rivner, Morteza Shamsnia, Thomas R. Swift, & G.S. Sohal. (1988). Growth of skeletal muscle from patients with amyotrophic lateral sclerosis transplanted into nude mice. Muscle & Nerve. 11(1). 33–38. 4 indexed citations
19.
Rivner, Michael H., et al.. (1988). Herpes Zoster Causing Acute Urinary Retention. Southern Medical Journal. 81(7). 929–930. 8 indexed citations
20.
Rivner, Michael H., et al.. (1988). False positive electrodiagnostic tests in carpal tunnel syndrome. Muscle & Nerve. 11(5). 511–518. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Swanson Breakdown of academic impact, for papers by Ming‐Hong Chang Breakdown of academic impact, for papers by Vivian E. Drory Breakdown of academic impact, for papers by David N. Herrmann Breakdown of academic impact, for papers by Alfred C. Lais Breakdown of academic impact, for papers by David N. Herrmann Breakdown of academic impact, for papers by Hideto Miwa Breakdown of academic impact, for papers by Páll Karlsson Breakdown of academic impact, for papers by Grazia Devigili Breakdown of academic impact, for papers by Akira Inaba
Rankless by CCL
2026